New distribution settlement may result in a swift restoration
Renalytix (LSE:RENX) is at 5.35p with a £26m market cap and studies unaudited outcomes for the 12 months to June 2026 following a change in FY to December, with no earnings progress however sturdy progress for the reason that interval finish. This precision medication diagnostics firm raised $14m at 6p, changing the remaining $3.6m of debt. The Company’s […]
The publish New distribution agreement could lead to a swift recovery appeared first on UK Investor Magazine.
